Moody’s assigns ‘A1’ rating to El Camino Hospital’s bonds

Moody’s Investors Service assigned an “A1” rating to Mountain View, Calif.-based El Camino Hospital’s proposed $286 million of series 2017 fixed-rate revenue bonds and maintained the “A1” rating on ECH’s parity revenue bonds.

Advertisement

The ratings agency also assigned an “Aa1” rating to Mountain View, Calif.-based El Camino Healthcare District’s $94.5 million of 2017 general obligation refunding bonds and maintained the “Aa1” rating on the district’s $133.7 million of outstanding parity debt.

The “A1” ratings assignment is based on ECH’s favorable balance sheet, utilization and operating performance metrics. The “Aa1” rating on the healthcare district’s debt is based on its large and diverse tax base, modest debt burden and strong financial position, according to Moody’s.

The outlook for the hospital is stable, reflecting Moody’s Investors Service’s expectation ECH will continue to achieve favorable operating measures in the foreseeable future and that its debt measures will improve over time. Moody’s did not assign an outlook to the healthcare district.

More articles on healthcare finance:
Rite Aid shares continue to slide after releasing merger proxy statements with Walgreens Boots Alliance
11 recent hospital outlook and credit rating actions
Moody’s affirms ‘#Aaa’ rating to CentraCare Health System’s bonds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.